Vaccinations against respiratory infections in Arabian Gulf countries: Barriers and motivators

Table 4 Significant predictors associated with vaccines uptake

Predictors	Adjusted OR	95%CI	P value
Influenza vaccine
Smoking (< 10 sig)	1.95	1.35-2.83	< 0.01
Smoking (11-20 sig)	2.23	1.63-3.05	< 0.01
Smoking (> 20 sig)	1.75	1.04-2.96	0.04
Other respiratory disease	0.15	0.04-0.61	< 0.01
Cancer	3.05	1.29-7.21	0.01
Immune disease	5.08	1.98-13.03	< 0.01
Pneumococcal vaccine
Male	1.90	1.23-2.93	< 0.01
Bachelor degree	0.64	0.45-0.90	0.01
Postgraduate	2.11	1.14-3.90	0.02
Smoking (> 30 sig)	4.60	2.64-7.99	< 0.01
KSA	0.31	0.15-0.66	< 0.01
Qatar	16.77	7.11-39.54	< 0.01
Kuwait	20.4	9.34-44.52	< 0.01
Meningococcal vaccine
Postgraduate degree	2.24	1.38-3.62	< 0.01
Diabetes	2.67	1.80-3.95	< 0.01
Asthma	1.78	1.17-2.70	< 0.01
Cardiovascular disease	3.43	1.30-9.01	< 0.01
Age (16-36)	0.45	0.29-0.70	< 0.01
Age (37-55)	0.26	0.14-0.47	< 0.01
KSA	3.15	1.96-5.08	< 0.01
UAE	8.01	4.68-13.71	< 0.01
Bahrain	12.09	6.52-22.43	< 0.01
Pertussis vaccine
Having chronic disease	4.81	3.49-6.62	< 0.01
Male	4.82	2.82-8.24	< 0.01
Smoking (11-20 sig)	1.89	1.30-2.75	< 0.01
Smoking (> 30 sig)	4.50	2.64-7.69	< 0.01
KSA	0.01	0.01-0.02	< 0.01
Qatar	0.05	0.02-0.12	< 0.01
UAE	0.02	0.01-0.05	< 0.01
Bahrain	0.03	0.01-0.07	< 0.01
Kuwait	0.08	0.04-0.16	< 0.01

KSA: Kingdom of Saudi Arabia; UAE: United Arab Emirate.